Should I Buy CASI? CASI 2026 Analysis

Should You Buy CASI Pharmaceuticals Inc (CASI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

0.920

1 Day change

-2.63%

52 Week Range

3.090

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient investor: trend is still bearish and near-term pattern odds point to further drift lower.
No fresh news/catalysts and no proprietary buy signals to justify taking risk into a micro-cap name.
Extremely high implied volatility + thin options volume suggests speculative pricing and poor risk/reward for a “buy now” entry.

Technical Analysis

Pre-market price: 0.99, sitting just above the pivot support area (Pivot 0.981); a clean break below pivot increases risk of testing S1 0.926 (then S2 0.892).
Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), signaling a broader downtrend despite small short-term bounces.
MACD histogram is slightly positive (0.00192) but positively contracting, indicating fading upside momentum rather than a strong reversal.
RSI(6) = 48.84 (neutral): no oversold bounce signal.
Upside levels to reclaim for a bullish shift: R1 1.035 then R2 1.069; until then, rallies look more like sellable pops.
Quant/pattern read: ~70% chance of -0.85% next day, -2.22% next week, -3.21% next month (bearish bias).

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Options positioning is call-only by data: Call OI 324 vs Put OI 0 (Put/Call OI ratio = 0), and today’s volume is tiny (2 calls, 0 puts).
Implied volatility is extremely elevated (30D IV ~910.84; IV percentile 98; IV rank 90.39), implying the market is pricing large moves—often a sign of distress/speculation.
Liquidity is very thin (today volume 2; 5D avg 6.2), so options-based sentiment is low-confidence and can be noisy.
Takeaway: options market looks speculative/illiquid rather than indicating a durable bullish consensus.

Technical Summary

Sell

Buy

Positive Catalysts

- NULL identified in the past week (no news flow).
- Net loss and EPS improved YoY in 2025/Q3 (loss narrowed), which is directionally positive, but not enough to offset revenue/margin deterioration.
- Trading trends: hedge funds neutral; insiders neutral (no obvious distribution signal, but also no confidence-boosting accumulation).

Neutral/Negative Catalysts

- No near-term catalysts (no recent news) to force a re-rating higher.
- 2025/Q3 revenue collapse (-60.54% YoY) and gross margin compression (-55.77% YoY) are significant fundamental headwinds.
- Bearish technical structure (long-term downtrend via moving averages) with price hovering near key support (pivot 0.981).
- Extreme IV suggests the market expects large moves; without positive catalysts, that can skew downside.
- Similar-pattern forecast points to continued weakness over 1D/1W/1M horizons.

Financial Performance

Latest quarter: 2025/Q3.
Revenue: 3.075M, down -60.54% YoY (major contraction).
Gross margin: 22.96%, down -55.77% YoY (profitability pressure).
Net income: -10.883M, improved 29.64% YoY (loss narrowed, but still meaningfully negative).
EPS: -0.68, improved 23.64% YoY (still loss-making).
Overall: cost/loss improvements are overshadowed by sharp top-line and margin deterioration—weak growth trend.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating / price target change data was provided, so no confirmed recent trend in Wall Street upgrades/downgrades.
Practical “pros vs cons” view based on available data: Pros—loss narrowing YoY; Cons—revenue and margins deteriorating sharply, bearish trend, and no visible catalysts.

1 Analyst Rating

Wall Street analysts forecast CASI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CASI is 4 USD with a low forecast of 4 USD and a high forecast of 4 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.950

Low

Averages

High

Current: 0.950

Low

Averages

High

HC Wainwright & Co.

Sean Lee

Strong Buy

Maintains

$6 → $4

AI Analysis

2025-04-09

Reason